Update on COVID-19 Treatment Development

Introduction

COVID-19 treatment development is moving at an unprecedented pace across the world and resulting therapeutics may be critical to reducing disease burden and pressure on the health system. This memo provides a brief review of accelerated development efforts, the types of treatments being studied, and information about outcomes of select studies.

Early results and expedited regulatory pathways have already sparked discussions about availability of effective treatments as they emerge. The promise of reducing mortality, morbidity, and burden on the health care system while awaiting a vaccine is driving unprecedented partnerships and global investments.

All NGA coronavirus memos can be found here, or visit Coronavirus: What You Need To Know for current information on the status of COVID-19 In The United States, a list of actions states/territories have taken to address both the public health and economic impacts, and policy resources.